• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Artiva Biotherapeutics, Inc. - Common Stock (NQ: ARTV )

    12.93 +1.03 (+8.66%)
    Streaming Delayed Price Updated: 11:09 AM EST, Nov 6, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 16,662
    Open 11.88
    Bid (Size) 12.51 (1)
    Ask (Size) 12.94 (1)
    Prev. Close 11.90
    Today's Range 11.88 - 13.22
    52wk Range 9.680 - 17.31
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Artiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its Board of Directors
    From Artiva Biotherapeutics, Inc.
    Via GlobeNewswire
    Artiva Biotherapeutics to Participate in the 2024 Cantor Fitzgerald Global Healthcare Conference
    From Artiva Biotherapeutics, Inc.
    Via GlobeNewswire

    Performance

    YTD
    +7.75%
    +7.75%
    1 Month
    -10.89%
    -10.89%
    3 Month
    +16.59%
    +16.59%
    6 Month
    +7.75%
    +7.75%
    1 Year
    +7.75%
    +7.75%

    More News

    Read More
    Artiva Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
    From Artiva Biotherapeutics, Inc.
    Via GlobeNewswire
    This Biotech IPO Stock Aims to Seize a Multibillion-Dollar Market with Its Innovative Treatment
    Via The Motley Fool
    Topics Initial Public Offering
    Exposures Securities Market
    Artiva Biotherapeutics' Investigational Scalable Cell Therapies For Autoimmune Disorders, Analyst Initiate With Bullish Pitch
    Via Benzinga
    Topics Initial Public Offering
    Exposures Securities Market
    Week In Review: Nanjing Triastek Partners With BioNTech In A $1.2 Billion Drug Development Deal
    Via Talk Markets
    Ardent Health Slips After Downsized IPO
    Via Talk Markets
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.